Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Core Insights - Myriad Genetics and SOPHiA GENETICS have announced a strategic collaboration to develop a global liquid biopsy companion diagnostic test for pharmaceutical companies [1] Company Overview - Myriad Genetics is recognized as a leader in molecular diagnostic testing and precision medicine [1] - SOPHiA GENETICS is an AI technology company focused on transforming precision medicine [1] Collaboration Details - The collaboration aims to innovate and provide pharmaceutical companies with advanced diagnostic solutions [1]